Bizarre Patents
An aircraft having vertical takeoff and landing capability provided with at least first and second laterally extending paddle wheels rotatable on a central axis perpendicular to the longitudinal axis of the aircraft fuselage and between its nose and tail.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7166287 | Viral agent The invention relates to post-transfusional non-A non-B hepatitis viral polypeptide, DNA sequences encoding such viral polypeptide, expression vectors containing such DNA sequences, and hosts transformed by such expression vectors. The invention also relates to the ... | 01/23/2007 |
| 7119202 | Substituted-1,3-oxathiolanes and substituted-1,3-dioxolanes with antiviral properties Disclosed are compounds of the formula wherein R1 is hydrogen or an acyl group having 1 to 16 carbon atoms; R2 is a purine or pyrimidine base or an analogu... | 10/10/2006 |
| 7008623 | Antibodies to CD23, derivatives thereof, and their therapeutic uses The invention relates to antibodies which bind to the CD23 (FCεRII) type II molecule particularly altered antibodies including antibodies which bind to the CD23 (FCεRII) type II molecule characterized by an affinity constant equal to or greater than 1×109 | 03/07/2006 |
| 6913930 | Analytical method and apparatus therefor involving continuous titration The present invention relates to an improved analytical method and apparatus therefor, in particular to a method and apparatus for continuous titration in which at least one parameter of at least one compound in a test mixture may be monitored as the composition of ... | 07/05/2005 |
| 6875449 | Crystal structure A process for the production of crystals with controlled surface smoothness, size, shape and degree of crystallinity, compositions comprising such crystals, and the use of certain crystals, especially lactose, lactose monohydrate, fluticasone propionate, salmeterol ... | 04/05/2005 |
| 6767996 | Altered antibodies and their preparation An altered antibody chain is produced in which the CDR's of the variable domain of the chain are derived from a first mammalian species. The framework-encoding regions of DNA encoding the variable domain of the first species are mutated so that the mutated framework... | 07/27/2004 |
| 6706244 | Apparatus and methods for evaluating the quality of a combinatorial library of compounds Devices and methods are provided to facilitate the evaluation of the quality of a combinatorial library of compounds. One exemplary device comprises a holding plate having an array of apertures. A plurality of vials are removably held within the apertures. Each of t... | 03/16/2004 |
| 6096786 | Immunopotentiatory agent and physiologically acceptable salts thereof The present invention relates to the use of 4-(2-formyl-3-hydroxyphenoxymethyl) benzoic acid or physiologically acceptable salts thereof as an immunopotentiatory agent, compositions containing such a compound and their manufacture, combinations of such a ... | 08/01/2000 |
| 6054325 | Method and apparatus for transferring and combining distinct chemical compositions with reagents The invention provides exemplary systems, methods, and apparatus for distinctly allocating liquids containing chemical compositions or compounds to known locations in an organized manner so that assays may be performed on the compositions, or so that the ... | 04/25/2000 |
| 5889056 | Enzyme inhibitors A compound of formula (I) ##STR1## wherein R1 is a C1-6 straight or branched chain alkyl group, a C2-6 alkenyl group, a C2-6 alkynyl group, a C3-6 cycloalkyl group or a C3-6 cycloalkyl... | 03/30/1999 |
| 5817652 | Hypolipidaemic condensed 1,4-thiazepines The invention provides a compound of formula (I), wherein n is an integer of from 0 to 2; R is an optional substituent; R1 is hydrogen or C1-6 alkyl; R2 is an atom or group selected from hydrogen, C1-4 alkyl (in... | 10/06/1998 |
| 5585402 | Nitric oxide synthase inhibitors The present invention discloses a method for inhibiting tissue damage in mammals caused by pathological NO production, which comprises administering an effective tissue damage inhibition amount of a NO synthase inhibitor to said mammal. Preferably the NO ... | 12/17/1996 |
| 5503869 | Process for forming medicament carrier for dry powder inhalator A process for forming a medicament carrier for use in a dry powder inhalator device wherein the medicament carrier has at least one carrier screen portion. The carrier screen portion defines a plurality of interstices therein and carries a powdered medica... | 04/02/1996 |
